Device type · NQO
Prosthesis, Spinous Process Spacer/Plate
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
NQO
Orthopedic
Device class
Class III
FDA decisions since 2015
2
510(k), De Novo and PMA
Adverse event reports
30
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Prosthesis, Spinous Process Spacer/Plate
- Product code
- NQO
- Device class
- Class III
- Review panel
- Orthopedic
- Specialty
- Orthopedic Surgery, Spine
- FDA record
- Classification database entry for NQO
Latest FDA decisions
- DIAM Spinal Stabilization SystemBreakthroughPMA
P240043 · Decided Dec 10, 2025 · 369 days after receipt
Device type: Prosthesis, spinous process spacer/plate (NQO) · Orthopedic Surgery
Boston Scientific Neuromodulation
P140004 · Decided May 20, 2015 · 415 days after receipt
Device type: Prosthesis, spinous process spacer/plate (NQO) · Orthopedic Surgery
Reports received
30
Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.
Malfunction reports
8
27% of reports
Injury reports
21
70% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 9 | 3 | 0 | 0 |
| Jan 24 | 8 | 16 | 0 | 0 |
| Feb 24 | 7 | 2 | 0 | 0 |
| Mar 24 | 3 | 3 | 0 | 0 |
| Apr 24 | 13 | 10 | 0 | 0 |
| May 24 | 5 | 13 | 0 | 0 |
| Jun 24 | 9 | 4 | 0 | 0 |
| Jul 24 | 6 | 4 | 0 | 0 |
| Aug 24 | 4 | 6 | 0 | 0 |
| Sep 24 | 2 | 7 | 0 | 0 |
| Oct 24 | 10 | 4 | 0 | 0 |
| Nov 24 | 4 | 7 | 0 | 0 |
| Dec 24 | 7 | 5 | 0 | 0 |
| Jan 25 | 6 | 3 | 0 | 0 |
| Feb 25 | 4 | 6 | 0 | 0 |
| Mar 25 | 6 | 6 | 0 | 0 |
| Apr 25 | 4 | 5 | 0 | 0 |
| May 25 | 2 | 1 | 0 | 0 |
| Jun 25 | 101 | 11 | 0 | 0 |
| Jul 25 | 4 | 4 | 0 | 0 |
| Aug 25 | 2 | 6 | 0 | 0 |
| Sep 25 | 0 | 3 | 0 | 0 |
| Oct 25 | 587 | 0 | 0 | 0 |
| Nov 25 | 1 | 3 | 0 | 0 |
| Dec 25 | 1 | 1 | 0 | 0 |
| Jan 26 | 0 | 2 | 0 | 0 |
| Feb 26 | 1 | 3 | 0 | 0 |
| Mar 26 | 0 | 1 | 0 | 0 |
| Apr 26 | 0 | 2 | 0 | 0 |
| May 26 | 1 | 2 | 0 | 0 |
| Jun 26 | 3 | 2 | 0 | 0 |
| Jul 26 | 0 | 2 | 0 | 0 |
| Aug 26 | 1 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 1 |
| Oct 26 | 0 | 3 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem12
- Lack of Effect10
- Mechanical Problem3
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions18
- Pain8
- Back pain5
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Boston Scientific Neuromodulation Corporation
Z-2485-2025 · Started Jun 6, 2025 · Posted by FDA Sep 2, 2025
Reason given: As a result of a comprehensive product performance review it was determine that the device and instruments are not consistently meeting expected performance levels. Issues include breakage of the instruments and implant/device.
Cause as FDA categorized it: Device Design
Boston Scientific Neuromodulation Corporation
Z-1972-2023 · Started May 12, 2023 · Posted by FDA Jun 15, 2023
Reason given: Pending update to indirect decompression system instructions for use informing users that excessive force during the implant procedure may cause driver instrument tip breaks, which may result in metal fragments (Driver teeth/tips) within the implant location; and if metal fragments are not removed and remain in situ,...
Cause as FDA categorized it: Labeling design
- Superion Indirect Decompression System (IDS) Model Numbers and Size: 101-9808 - 8mm 01-9812 - 12mm 101-9814 - 14mmOpen, Classified
Boston Scientific Neuromodulation Corporation
Z-0230-2023 · Started Oct 12, 2022 · Posted by FDA Nov 14, 2022
Reason given: Due to Indirect Decompression System devices exhibiting a potential for weld breakage at the spindle cap-to-main body interface. As a result of the separation of the spindle cap from the main body it may prevent proper deployment of the device during implantation.
Cause as FDA categorized it: Process change control
3 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.